Updates on AHPA activities and resources delivered to your inbox. Subscribe today!
Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.
The June AHPA Report includes recent AHPA presentations at NIH, USP, CFSAN, plus legal and regulatory updates, recent AHPA news and advocacy and much more.
More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff.